Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier product

Authors:

Abstract
No abstract available
Funding Information
  • PATH (00945)

This publication has 16 references indexed in Scilit: